title: Surgical treatment of Budd-Chiari syndrome.
abstract: Shunting and transplantation are satisfactory methods of treating Budd-Chiari syndrome (BCS). Selection of treatment is based on the degree of hepatic injury (clinical settings), liver biopsy results, potential for parenchymal recovery, and pressure measurements. Shunting is recommended in cases of preserved hepatic function and architecture. In the presence of fulminant forms of BCS, in cases of established cirrhosis or frank fibrosis, or for patients with defined hepatic metabolic defects (e.g., protein C or protein S deficiency), liver transplantation is the treatment of choice. Nonsurgical alternatives, although encouraging, have limited long-term outcome results at the present time. In most cases of BCS, a thrombophilic disorder can be identified. However, it is important to note that postoperative vascular thrombosis has been identified in patients with BCS who do not have a definable hypercoagulable predisposition. It therefore is our practice to recommend early (<24 hours postoperatively) initiation of intravenous heparin therapy in all patients with BCS, who then undergo life-long anticoagulation with coumadin.
authors.affiliation: Department of Surgery, Division of Transplantation, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. aklein@jhmi.edu
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Klein
authors.forename: Ernesto P
authors.initials: EP
authors.lastname: Molmenti
mesh_terms: D006502:Budd-Chiari Syndrome / Q000601:surgery*; D006801:Humans; D016031:Liver Transplantation